Alpha‐lipoic acid for diabetic peripheral neuropathy
Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
To assess the effects of alpha‐lipoic acid on symptoms, impairment and neurophysiological attributes in established diabetic peripheral neuropathy.